Skip to main content
Cancer Explained
Donate

NewsPublic figure

Carly Simon's Breast Cancer Story — and What the Diagnosis Means

Singer Carly Simon shared her breast cancer diagnosis in the late 1990s. Here's what breast cancer really is, in plain, NCI-sourced language.

By Cancer Explained Editorial TeamPublished Updated

A plain-language summary based on public reporting and trusted sources, linked below.

An older man and a female doctor review scan images together in a clinic
An older man and a female doctor review scan images together in a clinic — illustrative photograph, not of anyone named in this story.

Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.

Why she talked about it

CNN reported on 5 May 1998 that Carly Simon had breast cancer and was having chemotherapy. Her record company confirmed it.

The details she gave are unusually specific for the era. She was diagnosed in October 1997. A malignant tumor was removed from her breast. She spent one night in the hospital.

Her reason for speaking at all was practical. She told the New York Daily News she went public because the National Enquirer was preparing a story that might exaggerate her condition.

One sentence in that interview is worth pulling out, because it describes a decision thousands of people face every year. "Because they got everything during the procedure — and the prognosis was good — my doctor gave me the option of whether to have chemo. I decided to play it safe."

That is the whole logic of adjuvant treatment, in one quote. The rest of this page unpacks it.

What "they got everything" means

NCI notes that most people with breast cancer will have surgery. So will most people with ductal carcinoma in situ. The operation removes the tumor and nearby breast tissue. There are two main forms.

A lumpectomy removes the tumor and a rim of tissue around it, leaving the rest of the breast. It is also called breast-conserving surgery. When more tissue has to come out, other names are used: partial mastectomy, segmental mastectomy, or quadrantectomy.

A mastectomy removes the whole breast, with or without reconstruction.

NCI sets out when a lumpectomy plus radiation is likely to be offered. The cancer should be small relative to the breast, and in only one place. The person should not be pregnant, and should be able to attend daily radiation for up to 6 weeks.

The rim of tissue is the point. After a lumpectomy, a pathologist checks it for cancer or DCIS. If either is found there, more surgery may be needed. That check is what a phrase like "they got everything" is reporting.

Most people go home the same day and are back to normal activities within about two weeks. Our page on breast cancer covers the operations in more detail.

The lymph nodes get checked too

Breast cancer surgery usually includes looking at nearby lymph nodes.

The standard method is a sentinel lymph node biopsy. The sentinel node is the first one that fluid from the tumor area drains into. If cancer has begun to travel, that is where it should turn up first. Taking that one node avoids removing many others for no reason.

It is often done during the lumpectomy or mastectomy itself, and sometimes as a separate operation. Our page on cancer diagnosis explains how pathologists report these findings.

Why chemotherapy was a choice, not an order

Chemotherapy given after surgery is called adjuvant chemotherapy. Its job is to kill cells that may have left the breast before the operation. That lowers the chance the cancer returns.

Because it treats a possibility rather than a visible tumor, it is not automatic. NCI lists the situations where a doctor may recommend it after surgery:

  • High-grade breast cancer, meaning grade 3
  • Cancer that has spread to the lymph nodes
  • Triple-negative breast cancer
  • Inflammatory breast cancer

Chemotherapy can also be given before surgery, when it is called neoadjuvant. NCI describes several reasons. It can shrink a large tumor so breast-conserving surgery becomes possible. It can cut the number of lymph nodes that need removing. And it can lower the risk of recurrence.

NCI lists the drugs used. They include anthracyclines such as doxorubicin and epirubicin. They include taxanes such as paclitaxel and docetaxel. Others are cyclophosphamide, capecitabine, fluorouracil, gemcitabine, methotrexate, and platinum agents.

Most people who have a lumpectomy also have radiation once they heal, to stop cancer returning in the same breast. Hormone therapy and targeted therapy may be added depending on the tumor's biology.

What guides that decision now

In 1997, the choice Simon describes rested largely on tumor size, grade, and node status. It was a judgment call.

Since then, multigene tests have made it less of one. These read a panel of genes from the tumor itself. From that they estimate how likely the cancer is to return, and how much benefit chemotherapy would add. NCI lists these tests alongside other biomarker testing as part of how treatment is now planned.

That does not remove the decision. It narrows the uncertainty around it.

When to get checked

Screening exists because early breast cancer usually causes nothing at all. Between mammograms, these changes are the ones to report:

  • A lump in or near the breast, or under the arm
  • A thick or firm area that was not there before
  • A change in the size or shape of a breast
  • Nipple discharge that is not breast milk, or a nipple that flattens or changes direction
  • Skin that is scaly, swollen, red, darkened, dimpled, or puckered
  • Swelling of the breast with no lump

Most of these turn out to be benign. The point is not to panic at them, but to have them looked at rather than watched for months.

What this story does not settle

Simon's tumor was removed. Her prognosis was described as good, and chemotherapy was optional. That combination describes one situation, not a general rule. Someone with node-positive or triple-negative disease is not offered the same choice.

The account is also from 1998. Screening intervals, receptor testing, genomic risk scores, and drug options have all moved on. It is not a guide to current treatment.

What holds up is the reasoning. Surgery deals with what can be seen. Adjuvant treatment deals with what cannot. How much of the second is needed depends on the tumor itself. That is a conversation with numbers in it, not a coin toss.

Sources

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Put the story in context

Prevention, possible warning signs, screening, and diagnosis

This story relates to Breast cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.

  • Prevention and risk reduction

    Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.

    NCI prevention information

  • Symptoms and possible early signs

    Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.

    NCI signs and symptoms

  • Screening and early detection

    Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.

    NCI cancer screening information

  • How cancer is diagnosed

    Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.

    NCI diagnosis information

A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.

Go deeper with NCI